Effects of Aqueous Extract of Moringa oleifera on Phenylhydrazine-induced Liver Toxicity in Wistar Rats
Moringa oleifera has been shown to have a variety of medicinal benefits, including hepatoprotective effects. Phenylhydrazine has been used to cause hepatotoxicity in experimental models. In this study, an aqueous extract of Moringa oleifera was used to evaluate the ameliorating properties of phenylhydrazine-induced liver damage by assessing liver enzymes and histoarchitecture employing twenty-five (25) mature Wistar rats were divided into five (5) groups. Group A received 1 ml distilled water, Group B received 50 mg/kg phenylhydrazine twice in 48 hours, Group C received 500 mg/kg body weight of Moringa oleifera aqueous extract for four (4) weeks, Group D received 50 mg/kg phenylhydrazine twice in 48 hours and 500 mg/kg body weight of Moringa oleifera aqueous extract for four (4) weeks, and Group E received 50 mg/kg of phenylhydrazine twice in forty-eight (48) hours and 70 mg/kg body weight of Silymarin for four (4) weeks. After the administration of phenylhydrazine, significant increases (P<0.05) in the mean concentrations of liver enzymes (ALP, AST, ALT) and total protein were observed, whereas treatment with Moringa oleifera resulted in a reversal of those parameters to values comparable to the control and the standard drug - Silymarin. Overall, the results showed that Moringa oleifera aqueous extract had considerable hepatoprotective capability against phenylhydrazine-induced hepatotoxicity.